| Katie Tillman Cecil, | |
|
16045 S Brookfield St, Olathe, KS 66062-3933 | |
| (913) 553-0453 | |
| Not Available |
| Full Name | Katie Tillman Cecil |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 16045 S Brookfield St, Olathe, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023773199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1201 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katie Tillman Cecil, 16049 S Brookfield St, Olathe, KS 66062-3933 Ph: (913) 553-0453 | Katie Tillman Cecil, 16045 S Brookfield St, Olathe, KS 66062-3933 Ph: (913) 553-0453 |
News Archive
BG Medicine, Inc. announced today that it has entered into an agreement with Siemens Healthcare Diagnostics Inc., a division of Siemens Healthcare, one of the world's largest suppliers of clinical diagnostics to the healthcare industry, for the development and commercialization of a galectin-3 test for Siemens' automated immunoassay platforms for clinical laboratories.
Huntington's disease, cystic fibrosis, and muscular dystrophy are all diseases that can be traced to a single mutation. Diagnosis in asymptomatic patient for these diseases is relatively easy - You have the mutation? Then you are at risk. Complex diseases, on the other hand, do not have a clear mutational footprint.
CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Celsion Corporation today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology 2010 Annual Meeting.
› Verified 9 days ago
Megan Lynn Thomas, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15130 W 132nd St, Olathe, KS 66062 Phone: 913-609-0705 | |
Mr. Lawrence P Lehman, ACSW/LSCSW/LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 601 N Mur Len Rd, Suite 6, Olathe, KS 66062 Phone: 913-390-8719 Fax: 913-390-8719 | |
Mrs. Cassandra F Deforest, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21350 W 153rd St, Olathe, KS 66061 Phone: 913-322-2400 Fax: 913-621-5730 | |
Erin Stucky, LSCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21350 W 153rd St, Olathe, KS 66061 Phone: 913-322-2400 Fax: 913-621-5730 | |
Mrs. Megan Lee Hosterman, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21350 W 153rd St, Olathe, KS 66061 Phone: 913-322-2400 Fax: 913-621-5730 | |
Mr. Karlous U Kalu, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21350 W 153rd St, Olathe, KS 66061 Phone: 913-322-2400 Fax: 913-621-5730 |